Inactive Instrument

Highlights SPK Acquisition Corp.

Equities

SPK

US8486511053

Highlights

Unlock all the news: Be the first to know and act before the market!

SPK Acquisition Terminates Merger Agreement With Varian Biopharmaceuticals	22-12-27	MT
Varian Biopharmaceuticals Inc. cancelled the acquisition of SPK Acquisition Corp.	22-12-20	CI
SPK ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
SPK Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
SPK ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-08-15	AQ
SPK Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
SPK ACQUISITION CORP. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	22-07-13	AQ
SPK ACQUISITION CORP. Non-Reliance on Previous Financials, Audits or Interim Review, Financial Statements and Exhibits (form 8-K/A)	22-06-17	AQ
SPK Acquisition : Amendment to Current Report (Form 8-K/A)	22-06-07	PU
SPK ACQUISITION CORP. Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K/A)	22-06-07	AQ
SPK Acquisition : Current Report (Form 8-K)	22-05-25	PU
SPK ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	22-05-25	AQ
SPK Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-18	CI
SPK ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-05-18	AQ
SPK Acquisition : C O R P O R A T E P A R T I C I P A N T S - Form 8-K	22-02-28	PU
SPK ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	22-02-24	AQ
SPK Acquisition : Varian Biopharmaceuticals, Inc., a Precision Oncology Company, to Become Publicly Traded Through a Merger with SPK Acquisition Corp - Form 8-K	22-02-17	PU
SPK Acquisition Enters Deal to Merge With Varian Biopharmaceuticals	22-02-14	MT
Varian Biopharmaceuticals Inc. entered into a definitive agreement to acquire SPK Acquisition Corp. for $44.9 million in a reverse merger transaction.	22-02-13	CI
SPK ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	21-07-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights SPK Acquisition Corp.

Equities

SPK

US8486511053

Highlights

Filters